Connect
Picking up the pace with rollout of COVID-19 vaccines
The distribution kinks for COVID-19 vaccines are getting ironed out, says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland. "And the production of the vaccine is just going to accelerate."
Dr. Poland also repeats the reminders about preventing transmission of COVID-19:
- Wear a mask.
- Wash your hands.
- Keep your social distance.
"The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and herd immunity, as well as fertility issues related to COVID-19, survivor brain fog and more.
To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing. The sound and video quality are representative of the technology used. For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Connect with others talking about the pandemic and supporting one another in the COVID-19 support group.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.
Like
Helpful
HugInterested in more newsfeed posts like this? Go to the Podcasts blog.
Connect
I take daily blood thinner for Factor V Leiden. Three questions: 1) Do I have increased risk associated w the blood clotting aspect of Covid-19, and does the Jantoven help/hinder this aspect of the virus. 2) I thought the vaccine worked w key/keyhole btw Covid-19 & S protein. Is that the "immunity" mechanism, and is this a true immunity if I'm not manufacturing antibodies to COVID-19 itself. 3) Will any of the available vaccines have more/less risks associated with the Factor V Leiden & Jantoven use. I understand Covid-19 overall is a vast topic, but I am having great difficulty obtaining answers from any M.D. and would Really Appreciate clarification(s). I am open to contact through text or e-mail if requested. Thank you to everyone for who you are, and what you do!
C.Frederick